|
|
|
|
|
Anibal Pedraza, Lucia Gonzalez, Oscar Deniz and Gloria Bueno
HER2 overexpression is a prognostic and predictive factor observed in about 15% to 20% of breast cancer cases. The assessment of its expression directly affects the selection of treatment and prognosis. The measurement of HER2 status is performed by an e...
ver más
|
|
|
|
|
|
|
|
|
|
|
Jorge Juarez-Lucero, Maria Guevara-Villa, Anabel Sanchez-Sanchez, Raquel Diaz-Hernandez and Leopoldo Altamirano-Robles
Sodium dodecyl sulfate?polyacrylamide gel electrophoresis (SDS-PAGE) is used to identify protein presence, absence, or overexpression and usually, their interpretation is visual. Some published methods can localize the position of proteins using image an...
ver más
|
|
|
|
|
|
|
|
|
|
|
M. F. Mridha, Md. Kishor Morol, Md. Asraf Ali, MD SAKIB HOSSAIN SHOVON
Pág. 53 - 81
|
|
|
|
|
|
|
|
|
|
|
Katyayani Tatiparti, Mohd Ahmar Rauf, Samaresh Sau and Arun K. Iyer
Triple-negative breast cancer (TNBC) is amongst the most challenging tumor subtypes because it presents itself without the estrogen, progesterone, and HER2 receptors. Hence, assessing new markers is an essential requirement for enhancing its targeted tre...
ver más
|
|
|
|
|
|
|
|
|
|
|
Sandra Milena Sanabria Barrera, Lissette Carolina Sánchez Aranguren, Micael Hardy, Olivier Ouari, Marcos López Casillas
Pág. 8 - 9
El Cáncer Hepático o Carcinoma Hepatocelular (HCC) y el Cáncer de Seno Triple Negativo (por sus siglas en inglés TNBC, Triple Negative Breast Cancer), son problemas de salud pública en el mundo, por su difícil tratamiento y alta resistencia a la quimiote...
ver más
|
|
|
|
|
|